← Back to Search

TAP, Bupivacaine for Post-Gastric Bypass Surgery

Phase 1 & 2
Waitlist Available
Led By Karina Gritsenko, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes within arrival to pacu
Awards & highlights

Study Summary

Addition of transverse abdominis plane (TAP) block to general anesthesia for morbidly obese patients (BMI >35) undergoing laparoscopic bariatric surgery for weight loss will significantly reduce opioid use in the recovery room

Eligible Conditions
  • Post-Gastric Bypass Surgery
  • Transverse Abdominal Plane Blocks

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes within arrival to pacu
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes within arrival to pacu for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post Operative Opioid Usage
Secondary outcome measures
Nausea: The Number of Participants Experiencing Nausea Will be Assessed by Chart Review
Pain Score Assessed With Visual Analog Score (VAS)
Vomiting: The Number of Participants Experiencing Vomiting Will be Assessed by Chart Review

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TAP, BupivacaineExperimental Treatment2 Interventions
This group will receive general anesthesia and at the end of the operation, but still in the operating room, a single shot TAP block with 0.5% ropivacaine 15-20 ml / side under ultrasound guided technique with blunt tipped, 21 gauge needle.
Group II: No interventionActive Control1 Intervention
General anesthesia
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transverse abdominal plane block
2013
Completed Phase 2
~30
Bupivacaine
FDA approved

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
446 Previous Clinical Trials
582,755 Total Patients Enrolled
Karina Gritsenko, MDPrincipal InvestigatorMontefiore Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Regional TAP Block for Bariatric Patients
Karina Gritsenko 2013. "Regional TAP Block for Bariatric Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04051684.
~2 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top